Prevalence of Depression and Treatment in T2D Patients Varies by Race

Type 2 diabetes (T2D) patients are at risk for depression, which could negatively impact T2D-related outcomes. In this study, published in the Journal of Diabetes and its Complications, researchers evaluated the risk for depression in this patient population and the rate of antidepressant treatment based on race/ethnicity. The study authors conducted a cross-sectional study of baseline data on patients who were taking part in a cluster randomized trial that assessed a health literacy intervention for diabetes care in safety net clinics. The Center for Epidemiological Studies Depression Scale was used to establish depressive symptoms. Final analysis included 403 patients (mean age, 51 years; 60% were female); racial breakdown was 58% white, 18% black, and 24% Hispanic. Just over half (52%) of patients screened positive for depression, and 18% were being treated with antidepressants. Compared to white patients, black patients were significantly less likely to be taking an antidepressant (adjusted odds ratio [aOR]: 0.31, 95% CI, 0.12–0.80), as were Hispanic patients (aOR: 0.26; 95% CI, 0.10–0.74). The authors concluded that their findings suggest that T2D patients with low income and without health insurance have a lower likelihood of being treated for depression.